BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 11823129)

  • 1. Syntheses and pharmacological evaluation of two potent antagonists for dopamine D4 receptors: [11C]YM-50001 and N-[2-[4-(4-Chlorophenyl)-piperizin-1-yl]ethyl]-3-[11C]methoxybenzamide.
    Zhang MR; Haradahira T; Maeda J; Okauchi T; Kawabe K; Noguchi J; Kida T; Suzuki K; Suhara T
    Nucl Med Biol; 2002 Feb; 29(2):233-41. PubMed ID: 11823129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors.
    Hidaka K; Tada S; Matsumoto M; Ohmori J; Tasaki Y; Nomura T; Usuda S; Yamaguchi T
    Br J Pharmacol; 1996 Apr; 117(8):1625-32. PubMed ID: 8732269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbon-11 pb-12: an attempt to visualize the dopamine d(4) receptor in the primate brain with positron emission tomography.
    Langer O; Halldin C; Chou Y; Sandell J; Swahn C; Någren K; Perrone R; Berardi F; Leopoldo M; Farde L
    Nucl Med Biol; 2000 Nov; 27(8):707-14. PubMed ID: 11150701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging dopamine D4 receptors in the living primate brain: a positron emission tomography study using the novel D1/D4 antagonist [11C]SDZ GLC 756.
    Boy C; Klimke A; Holschbach M; Herzog H; Mühlensiepen H; Rota Kops E; Sonnenberg F; Gaebel W; Stöcklin G; Markstein R; Müller-Gärtner HW
    Synapse; 1998 Dec; 30(4):341-50. PubMed ID: 9826226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo evaluation of N-{2-[4-(3-Cyanopyridin-2-yl)piperazin-1-yl]ethyl}-3-[(11) C]methoxybenz-amide, a positron emission tomography (PET) radioligand for dopamine D4 receptors, in rodents.
    Leopoldo M; Selivanova SV; Müller A; Lacivita E; Schetz JA; Ametamey SM
    Chem Biodivers; 2014 Sep; 11(9):1298-308. PubMed ID: 25238073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-[2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl]-3-methoxybenzamide: a potent and selective dopamine D4 ligand.
    Perrone R; Berardi F; Colabufo NA; Leopoldo M; Tortorella V
    J Med Chem; 1998 Nov; 41(24):4903-9. PubMed ID: 9822559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, radiolabeling, and in vivo evaluation of carbon-11 labeled N-[2-[4-(3-cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-methoxybenzamide, a potential positron emission tomography tracer for the dopamine D(4) receptors.
    Lacivita E; De Giorgio P; Lee IT; Rodeheaver SI; Weiss BA; Fracasso C; Caccia S; Berardi F; Perrone R; Zhang MR; Maeda J; Higuchi M; Suhara T; Schetz JA; Leopoldo M
    J Med Chem; 2010 Oct; 53(20):7344-55. PubMed ID: 20873719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of 3-(4-chlorobenzyl)-8-[11C]methoxy-1,2,3,4-tetrahydrochromeno[3,4-c]pyridin-5-one: a PET tracer for imaging sigma(1) receptors.
    Zhang MR; Haradahira T; Maeda J; Okauchi T; Kawabe K; Kida T; Obayashi S; Suzuki K; Suhara T
    Nucl Med Biol; 2002 May; 29(4):469-76. PubMed ID: 12031882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, lipophilic properties, and binding affinities of potential ligands in positron emission tomography (PET) for visualization of brain dopamine D4 receptors.
    Lacivita E; De Giorgio P; Colabufo NA; Berardi F; Perrone R; Niso M; Leopoldo M
    Chem Biodivers; 2014 Feb; 11(2):299-310. PubMed ID: 24591318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo.
    Pike VW; Halldin C; McCarron JA; Lundkvist C; Hirani E; Olsson H; Hume SP; Karlsson P; Osman S; Swahn CG; Hall H; Wikström H; Mensonidas M; Poole KG; Farde L
    Eur J Nucl Med; 1998 Apr; 25(4):338-46. PubMed ID: 9553162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1.
    Primus RJ; Thurkauf A; Xu J; Yevich E; McInerney S; Shaw K; Tallman JF; Gallagher DW
    J Pharmacol Exp Ther; 1997 Aug; 282(2):1020-7. PubMed ID: 9262371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbon-11 epidepride: a suitable radioligand for PET investigation of striatal and extrastriatal dopamine D2 receptors.
    Langer O; Halldin C; Dollé F; Swahn CG; Olsson H; Karlsson P; Hall H; Sandell J; Lundkvist C; Vaufrey F; Loc'h C; Crouzel C; Mazière B; Farde L
    Nucl Med Biol; 1999 Jul; 26(5):509-18. PubMed ID: 10473189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.
    Millan MJ; Newman-Tancredi A; Brocco M; Gobert A; Lejeune F; Audinot V; Rivet JM; Schreiber R; Dekeyne A; Spedding M; Nicolas JP; Peglion JL
    J Pharmacol Exp Ther; 1998 Oct; 287(1):167-86. PubMed ID: 9765336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D3 and D4 receptor antagonists: synthesis and structure--activity relationships of (S)-(+)-N-(1-Benzyl-3-pyrrolidinyl)-5-chloro-4- [(cyclopropylcarbonyl) amino]-2-methoxybenzamide (YM-43611) and related compounds.
    Ohmori J; Maeno K; Hidaka K; Nakato K; Matsumoto M; Tada S; Hattori H; Sakamoto S; Tsukamoto S; Usuda S; Mase T
    J Med Chem; 1996 Jul; 39(14):2764-72. PubMed ID: 8709107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomographic evaluation of the putative dopamine-D3 receptor ligand, [11C]RGH-1756 in the monkey brain.
    Sóvágó J; Farde L; Halldin C; Langer O; Laszlovszky I; Kiss B; Gulyás B
    Neurochem Int; 2004 Oct; 45(5):609-17. PubMed ID: 15234102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of dopamine receptor subtypes in corpus striatum and nucleus accumbens septi of rat brain: comparison of D1-, D2-, and D4-like receptors.
    Tarazi FI; Campbell A; Yeghiayan SK; Baldessarini RJ
    Neuroscience; 1998 Mar; 83(1):169-76. PubMed ID: 9466407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New halogenated [11C]WAY analogues, [11C]6FPWAY and [11C]6BPWAY--radiosynthesis and assessment as radioligands for the study of brain 5-HT1A receptors in living monkey.
    Sandell J; Halldin C; Pike VW; Chou YH; Varnäs K; Hall H; Marchais S; Nowicki B; Wikström HV; Swahn CG; Farde L
    Nucl Med Biol; 2001 Feb; 28(2):177-85. PubMed ID: 11295428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D4-like binding sites labeled by [3H]nemonapride include substantial serotonin 5-HT2A receptors in primate cerebral cortex.
    Noda-Saita K; Matsumoto M; Hidaka K; Hatanaka K; Ohmori J; Okada M; Yamaguchi T
    Biochem Biophys Res Commun; 1999 Feb; 255(2):367-70. PubMed ID: 10049714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-[4-(3,4-Dimethylphenyl)piperazin-1-ylmethyl]-1H benzoimidazole (A-381393), a selective dopamine D4 receptor antagonist.
    Nakane M; Cowart MD; Hsieh GC; Miller L; Uchic ME; Chang R; Terranova MA; Donnelly-Roberts DL; Namovic MT; Miller TR; Wetter JM; Marsh K; Stewart AO; Brioni JD; Moreland RB
    Neuropharmacology; 2005 Jul; 49(1):112-21. PubMed ID: 15992586
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.